Selecta Biosciences, Inc. (SELB) Reaches $11.59 After 7.00% Down Move; Tdh Holdings Inchares (PETZ) Sellers Increased By 81.89% Their Shorts

May 21, 2018 - By Marie Mckinney

Tdh Holdings Inchares (NASDAQ:PETZ) had an increase of 81.89% in short interest. PETZ’s SI was 194,800 shares in May as released by FINRA. Its up 81.89% from 107,100 shares previously. With 40,200 avg volume, 5 days are for Tdh Holdings Inchares (NASDAQ:PETZ)’s short sellers to cover PETZ’s short positions. The SI to Tdh Holdings Inchares’s float is 4.69%. The stock increased 2.65% or $0.1 during the last trading session, reaching $3.88. About 32,578 shares traded. TDH Holdings, Inc. (NASDAQ:PETZ) has 0.00% since May 21, 2017 and is . It has underperformed by 11.55% the S&P500.

The stock of Selecta Biosciences, Inc. (NASDAQ:SELB) is a huge mover today! The stock decreased 4.92% or $0.6 during the last trading session, reaching $11.59. About 73,064 shares traded. Selecta Biosciences, Inc. (NASDAQ:SELB) has declined 20.81% since May 21, 2017 and is downtrending. It has underperformed by 32.36% the S&P500.The move comes after 9 months negative chart setup for the $259.03M company. It was reported on May, 21 by Barchart.com. We have $10.78 PT which if reached, will make NASDAQ:SELB worth $18.13 million less.




More recent Selecta Biosciences, Inc. (NASDAQ:SELB) news were published by: Globenewswire.com which released: “Selecta Biosciences to Present at Upcoming Investor Conferences” on May 01, 2018. Also Seekingalpha.com published the news titled: “Selecta Biosciences’ (SELB) CEO Werner Cautreels on Q1 2018 Results – Earnings Call Transcript” on May 09, 2018. Nasdaq.com‘s news article titled: “Selecta Biosciences Announces First Quarter 2018 Financial Results and Provides Corporate Update” with publication date: May 09, 2018 was also an interesting one.

Analysts await Selecta Biosciences, Inc. (NASDAQ:SELB) to report earnings on August, 10. They expect $-0.78 EPS, up 8.24% or $0.07 from last year’s $-0.85 per share. After $-0.71 actual EPS reported by Selecta Biosciences, Inc. for the previous quarter, Wall Street now forecasts 9.86% negative EPS growth.

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company has market cap of $259.03 million. The Company’s lead product candidate is SEL-212, which is in phase I/II clinical trials for the treatment of refractory and chronic tophaceous gout. It currently has negative earnings.

TDH Holdings, Inc. engages in the development, manufacture, and sale of pet food products for pet owners worldwide. The company has market cap of $36.56 million. It offers approximately 200 products, which include 5 product lines consisting of pet chews, dried pet snacks, wet canned pet food, dental health snacks, and baked pet biscuits, as well as non-food items. It has a 20.64 P/E ratio. The firm sells its products under the Pet Cuisine, Hum & Cheer, Like, TDH, Tiandihui, and Dog Zone Sasami names.

More recent TDH Holdings, Inc. (NASDAQ:PETZ) news were published by: Nasdaq.com which released: “Mid-Morning Market Update: Markets Open Lower; Pfizer Posts Mixed Q1 Results” on May 01, 2018. Also Prnewswire.com published the news titled: “TDH Holdings, Inc. Reports Fiscal Year 2017 Financial Results” on April 30, 2018. Benzinga.com‘s news article titled: “32 Stocks Moving In Tuesday’s Mid-Day Session” with publication date: May 01, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: